KEYS Keysight Technologies Inc

Keysight Announces Date of First Quarter 2025 Financial Results Conference Call

SANTA ROSA, Calif.--(BUSINESS WIRE)--

(NYSE: KEYS) will release financial results for the fiscal quarter ending January 31, 2025 after the close of the market on Tuesday, February 25, 2025. The company will host a conference call that day at 1:30 p.m. PT (4:30 p.m. ET) to review the financial results.

The conference call will be webcast live and accessible in the Upcoming Events section of the Keysight investor relations website, . The call can also be accessed by dialing 1-404-975-4839 or 1-833-470-1428 toll-free (access code 992044).

A replay of the conference call will be available for 90 days in the News, Events, Presentations section of the Keysight investor relations website.

About Keysight Technologies

At Keysight (NYSE: KEYS), we inspire and empower innovators to bring world-changing technologies to life. As an S&P 500 company, we’re delivering market-leading design, emulation, and test solutions to help engineers develop and deploy faster, with less risk, throughout the entire product lifecycle. We’re a global innovation partner enabling customers in communications, industrial automation, aerospace and defense, automotive, semiconductor, and general electronics markets to accelerate innovation to connect and secure the world. Learn more at and .

Source: IR-KEYS

EN
04/02/2025

Underlying

KEYSKeysight Technologies Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Keysight Technologies Inc

 PRESS RELEASE
Free
KEYS Keysight Techno...

Keysight to Demonstrate Wireless Innovations at Mobile World Congress ...

Keysight (NYSE: KEYS): What: At , Keysight will showcase how to empower the wireless future, with artificial intelligence (AI) and secure devices and networks to achieve breakthroughs in 5G-advanced and 6G research. Keysight pioneers innovation with connected intelligence by pushing the boundaries with an end-to-end wireless portfolio that enables advanced use cases, reduces risk, and speeds time to market.   When: March 3-6, 2025   Where: Hall 5, Keysight booth #5F41 Gran Via, Barcelona, Spain   Info: Keysight will present the following demonstratio...

February 21, 2025 1 EN
 PRESS RELEASE
Free
KEYS Keysight Techno...

Keysight Joins Forces with the EU to Drive Innovation in 6G

SANTA ROSA, Calif.--(BUSINESS WIRE)-- (NYSE: KEYS) is enhancing Europe’s 6G research and innovation landscape by participating in two projects that are a part of the , a research and innovation program co-funded by the European Union (EU). Keysight plays an active role in advancing 6G, AI, and metrology research in Europe by collaborating with service providers, vendors, research institutes, and universities. Through partnerships, Keysight contributes to crucial EU and government-funded research, as well as innovation and trial programs. These new initiatives are geared towards facilitating...

February 11, 2025 1 EN
 PRESS RELEASE
Free
KEYS Keysight Techno...

Keysight and Alea First to Validate 3GPP EUTRA Mission Critical Test C...

SANTA ROSA, Calif.--(BUSINESS WIRE)-- (NYSE: KEYS) and have validated the first* mission-critical 3GPP Evolved Universal Terrestrial Radio Access (EUTRA) test case for mission-critical-push-to-talk (MCPTT) at the recent Global Certification Forum (GCF) Conformance Agreement Group (CAG) meeting. The validation was conducted using the . Mission Critical Communications (MCX), including MCPTT, has emerged as a groundbreaking standard within the 3GPP, offering a reliable, efficient, and feature-rich communication solution for mission-critical situations such as public safety, security, transpor...

February 5, 2025 1 EN
 PRESS RELEASE
Free
KEYS Keysight Techno...

Keysight Announces Date of First Quarter 2025 Financial Results Confer...

SANTA ROSA, Calif.--(BUSINESS WIRE)-- (NYSE: KEYS) will release financial results for the fiscal quarter ending January 31, 2025 after the close of the market on Tuesday, February 25, 2025. The company will host a conference call that day at 1:30 p.m. PT (4:30 p.m. ET) to review the financial results. The conference call will be webcast live and accessible in the Upcoming Events section of the Keysight investor relations website, . The call can also be accessed by dialing 1-404-975-4839 or 1-833-470-1428 toll-free (access code 992044). A replay of the conference call will be available for...

February 4, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 47.78
OSK OSHKOSH CORP
VIAV Viavi Solutions... ... (+38)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

OSK OSHKOSH CORP
VIAV VIAVI SOLUTIONS INC
ROLL RBC BEARINGS INCORPORATED
NRIM NORTHRIM BANCORP INC.
KEYS KEYSIGHT TECHNOLOGIES INC
JBT JOHN BEAN TECHNOLOGIES CORPORATION
GLW CORNING INC
EMN EASTMAN CHEMICAL COMPANY
CIEN CIENA CORPORATION
CAMT CAMTEK LTD.
BMI BADGER METER INC.
BEN FRANKLIN RESOURCES INC.
TATT TAT TECHNOLOGIES LTD.
INTT INTEST CORP.
PLSE PULSE BIOSCIENCES
LCUT LIFETIME BRANDS
ISSC INNOVATIVE SOLUTIONS & SUPPORT INC.
SRTS SENSUS HEALTHCARE
FTG111 FLATEXDEGIRO AG
CVCO CAVCO INDUSTRIES INC.
ATGE ADTALEM GLOBAL EDUCATION INC.
JHG JANUS HENDERSON GROUP PLC
BKR BAKER HUGHES COMPANY CLASS A
INS INTELLIGENT SYSTEMS CORP.
AVGO BROADCOM INC.
CSPI CSP INC.
TSSI TSS INC
INMB INMUNE BIO
TARS TARSUS PHARMACEUTICALS
HIMS HIMS AND HERS HEALTH INC (A)
GTLB GITLAB INC
VERV VERVE THERAPEUTICS INC
LNSR LENSAR INC
TEAM ATLASSIAN CORPORATION
BKSY BLACKSKY TECHNOLOGY INC
BBCN39 JPMORGAN BETABUILDERS CANADA BDR
VATE INNOVATE CORP
MNPR MONOPAR THERAPEUTICS INC.
02/03/25 February 3, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch